Prognostic effects of co-occurring TP53 and KRAS aberrations in patients with advanced biliary tract cancer.

Authors

null

Taro Shibuki

Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan

Taro Shibuki , Yoshiaki Nakamura , Makoto Ueno , Masayuki Furukawa , Yasuyuki Kawamoto , Shinji Itoh , Kumiko Umemoto , Kentaro Sudo , Taroh Satoh , Nobumasa Mizuno , Akinori Asagi , Naohiro Okano , Satoshi Shimizu , Tanios S. Bekaii-Saab , John H Strickler , Takao Fujisawa , Hideaki Bando , Takayuki Yoshino , Chigusa Morizane , Masafumi Ikeda

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 538)

DOI

10.1200/JCO.2024.42.3_suppl.538

Abstract #

538

Poster Bd #

F5

Abstract Disclosures

Similar Posters

First Author: Mohamed Bouattour

First Author: Toru Otsuru